Humana Inc. (HUM) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Humana Inc. (HUM), Healthcare sektöründe faaliyet gösteriyor, son olarak 174.03$'dan işlem görüyor ve 21B piyasa değerine sahip. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 50/100 puan alıyor.
Son analiz: 9 Şub 2026Humana Inc. (HUM) Sağlık ve Boru Hattı Genel Bakışı
Humana Inc. (HUM) delivers integrated healthcare solutions, offering medical and supplemental benefit plans to a vast membership base. With a focus on well-being and a strong presence in Medicare and Medicaid programs, Humana presents a stable investment opportunity within the growing healthcare sector, bolstered by a 1.83% dividend yield.
Yatırım Tezi
Humana presents a notable research candidate within the healthcare sector, driven by its strong position in the Medicare Advantage market and its integrated healthcare service offerings. With a P/E ratio of 18.10 and a dividend yield of 1.83%, Humana offers a blend of value and income. Growth catalysts include the increasing adoption of Medicare Advantage plans and the expansion of its Healthcare Services segment. The company's focus on integrated care models and home-based services positions it well to capitalize on the growing demand for value-based healthcare. The company's beta of 0.44 suggests lower volatility than the overall market. Continued expansion in government-sponsored healthcare programs and strategic acquisitions could further enhance Humana's market share and profitability.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Humana serves approximately 17 million members in medical benefit plans as of December 31, 2021, showcasing a substantial market presence.
- The company operates with a Gross Margin of 100.0%, indicating efficient cost management in its healthcare service delivery.
- Humana's Profit Margin stands at 1.0%, reflecting the profitability of its diverse healthcare operations.
- The company offers a Dividend Yield of 1.83%, providing investors with a steady income stream.
- Humana's Beta of 0.44 suggests lower volatility compared to the broader market, making it a relatively stable investment.
Rakipler & Benzerleri
Güçlü Yönler
- Strong market position in Medicare Advantage.
- Diversified revenue streams across multiple segments.
- Integrated healthcare service offerings.
- Established relationships with government agencies.
Zayıflıklar
- Exposure to regulatory changes and healthcare policy risks.
- Dependence on government funding for a significant portion of revenue.
- Competition from other large health insurers.
- Profit margin is relatively low at 1.0%.
Katalizörler
- Ongoing: Continued growth in Medicare Advantage enrollment.
- Ongoing: Expansion of Healthcare Services segment.
- Upcoming: Potential strategic partnerships and acquisitions.
- Ongoing: Leveraging technology and data analytics to improve efficiency and outcomes.
- Ongoing: Expansion in Medicaid and dual eligible programs.
Riskler
- Potential: Changes in government healthcare policy and regulations.
- Ongoing: Increased competition from other health insurers.
- Ongoing: Rising healthcare costs.
- Potential: Cybersecurity threats and data breaches.
- Potential: Economic downturn affecting enrollment.
Büyüme Fırsatları
- Expansion of Medicare Advantage: The Medicare Advantage market is projected to continue growing as more seniors opt for managed care plans. Humana, with its established presence and expertise in this segment, is well-positioned to capture a significant share of this growth. By offering innovative plan designs and focusing on member engagement, Humana can attract new members and increase its market share. This expansion is expected to contribute significantly to revenue growth over the next 3-5 years.
- Growth in Healthcare Services: Humana's Healthcare Services segment, which includes pharmacy solutions, provider services, and home solutions, presents a significant growth opportunity. By expanding its home-based care services and leveraging technology to improve care coordination, Humana can enhance member outcomes and reduce costs. The market for home healthcare services is projected to grow as more patients seek convenient and cost-effective care options. This segment is expected to drive margin expansion and revenue diversification.
- Strategic Partnerships and Acquisitions: Humana can pursue strategic partnerships and acquisitions to expand its geographic reach and enhance its service offerings. By partnering with local healthcare providers and acquiring companies with complementary capabilities, Humana can strengthen its competitive position and accelerate growth. Potential acquisition targets include companies specializing in telehealth, data analytics, and behavioral health. These partnerships and acquisitions are expected to contribute to revenue growth and market share gains over the next 2-3 years.
- Leveraging Technology and Data Analytics: Investing in technology and data analytics can enable Humana to improve operational efficiency, personalize member experiences, and enhance care coordination. By leveraging data analytics to identify high-risk members and tailor interventions, Humana can improve health outcomes and reduce costs. The company can also use technology to streamline administrative processes and improve member engagement. These investments are expected to drive cost savings and improve member satisfaction over the long term.
- Expansion in Medicaid and Dual Eligible Programs: Humana has the opportunity to expand its presence in Medicaid and dual eligible programs by partnering with states to provide comprehensive healthcare services to underserved populations. By leveraging its expertise in managed care and its focus on integrated care models, Humana can improve health outcomes and reduce costs for Medicaid and dual eligible members. This expansion is expected to contribute to revenue growth and diversification over the next 3-5 years.
Fırsatlar
- Expansion in Medicare Advantage and Medicaid markets.
- Growth in Healthcare Services segment.
- Strategic partnerships and acquisitions.
- Leveraging technology and data analytics to improve efficiency and outcomes.
Tehditler
- Changes in government healthcare policy and regulations.
- Increased competition from other health insurers.
- Rising healthcare costs.
- Cybersecurity threats and data breaches.
Rekabet Avantajları
- Strong brand recognition and reputation in the Medicare Advantage market.
- Extensive network of healthcare providers and pharmacies.
- Expertise in managing healthcare costs and improving member health outcomes.
- Established relationships with government agencies and state Medicaid programs.
HUM Hakkında
Founded in 1961 and headquartered in Louisville, Kentucky, Humana Inc. has evolved into a leading health and well-being company in the United States. Initially a nursing home company, Humana transitioned into health insurance in the 1980s. Today, Humana operates through three segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment offers medical and supplemental benefit plans to individuals, including Medicare Advantage plans, which are a significant driver of revenue. The Group and Specialty segment provides commercial fully insured medical and specialty health insurance benefits, such as dental and vision, to employer groups. The Healthcare Services segment delivers pharmacy solutions, provider services, and home solutions, enhancing the overall value proposition for its members. As of December 31, 2021, Humana served approximately 17 million members in medical benefit plans and approximately 5 million members in specialty products. Humana also administers the Limited Income Newly Eligible Transition prescription drug plan program under contract with the Centers for Medicare and Medicaid Services (CMS) and partners with states to provide Medicaid and dual eligible benefits.
Ne Yaparlar
- Offers Medicare Advantage plans to individuals.
- Provides commercial medical and specialty health insurance benefits to employer groups.
- Administers the Limited Income Newly Eligible Transition prescription drug plan program.
- Contracts with states to provide Medicaid, dual eligible, and long-term support services benefits.
- Offers dental, vision, and other supplemental health benefits.
- Provides pharmacy solutions to health plan members and third parties.
- Offers provider services to health plan members and third parties.
- Delivers home health and other services to health plan members and third parties.
İş Modeli
- Generates revenue from premiums paid by members for medical and supplemental benefit plans.
- Earns fees from administering government-sponsored healthcare programs.
- Receives payments for providing pharmacy solutions, provider services, and home solutions.
- Profits from managing healthcare costs and improving member health outcomes.
Sektör Bağlamı
Humana operates in the dynamic and competitive healthcare plans industry. The industry is experiencing growth driven by an aging population, increasing healthcare costs, and the expansion of government-sponsored healthcare programs like Medicare and Medicaid. The market is dominated by large players offering a range of health insurance products and services. Humana competes with other major health insurers, such as CNC (Centene Corporation), focusing on providing comprehensive healthcare solutions and leveraging technology to improve member outcomes and reduce costs. The industry is also seeing a trend towards value-based care, with companies like Humana increasingly focusing on integrated care models and preventive services.
Kilit Müşteriler
- Individuals enrolled in Medicare Advantage plans.
- Employer groups offering commercial health insurance benefits to their employees.
- States contracting for Medicaid and dual eligible programs.
- Members seeking dental, vision, and other supplemental health benefits.
Finansallar
Grafik & Bilgi
Humana Inc. (HUM) hisse senedi fiyatı: $174.03 (-0.22, -0.12%)
Son Haberler
-
CommonSpirit, Humana reach new nationwide Medicare Advantage contract
Yahoo! Finance: HUM News · 24 Mar 2026
-
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop
Yahoo! Finance: HUM News · 23 Mar 2026
-
Humana (NYSE:HUM) Reaches New 52-Week Low – Here’s What Happened
defenseworld.net · 22 Mar 2026
-
1 Profitable Stock to Own for Decades and 2 We Question
Yahoo! Finance: HUM News · 20 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
HUM için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
Konsensüs hedefi: $222.23
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, HUM'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
CommonSpirit, Humana reach new nationwide Medicare Advantage contract
A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop
Humana (NYSE:HUM) Reaches New 52-Week Low – Here’s What Happened
1 Profitable Stock to Own for Decades and 2 We Question
HUM Healthcare Hisse Senedi SSS
HUM için değerlendirilmesi gereken temel faktörler nelerdir?
Humana Inc. (HUM) şu anda yapay zeka skoru 50/100, orta puanı gösteriyor. Hisse 17.6x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $222.23 ($174.03'dan +28%). Temel güçlü yan: Strong market position in Medicare Advantage.. İzlenmesi gereken birincil risk: Potential: Changes in government healthcare policy and regulations.. Bu bir finansal tavsiye değildir.
HUM MoonshotScore'u nedir?
HUM şu anda MoonshotScore'da 50/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
HUM verileri ne sıklıkla güncellenir?
HUM fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler HUM hakkında ne diyor?
Analistler, HUM için $222.23 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($174.03) yukarı yönlü %28 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.
HUM'a yatırım yapmanın riskleri nelerdir?
HUM için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in government healthcare policy and regulations.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
HUM'ın P/E oranı nedir?
Humana Inc. (HUM)'nın son P/E oranı 17.6, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.
HUM aşırı değerli mi, yoksa düşük değerli mi?
Humana Inc. (HUM)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 17.6. Analist hedefi $222.23 (mevcut fiyattan +28%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
HUM'ın temettü verimi nedir?
Humana Inc. (HUM) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Stock data pending update.
- Financial data as of December 31, 2021.